Search

everythinglearnresearchcommunity

for

Search:↓

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

New treatments are being explored to slow or reverse hereditary hair loss.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

CEC levels may be a useful marker for predicting prostate cancer progression.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Androgenetic alopecia is common hair loss caused by genetics and hormones.